{"id":"W3125989326","doi":"10.1101/2021.01.26.428337","title":"STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in <i>BRCA</i> -associated breast cancer","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Dana-Farber/Harvard Cancer Center; Ludwig Center at Harvard; National Institutes of Health; Sierra Oncology; Ipsen; Astex Pharmaceuticals; G1 Therapeutics; Pfizer; Merck KGaA; Array BioPharma; Eli Lilly and Company","keywords":"Cancer research; Immune system; Breast cancer; Stimulator of interferon genes; Cancer; PARP inhibitor; Proinflammatory cytokine; Poly ADP ribose polymerase; Medicine; Sting; Immunology; Dendritic cell; Immunotherapy; T cell; Pharmacology; Biology; Internal medicine; Innate immune system; Inflammation; Polymerase","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000929159,0.0001620487,0.0001765058,0.0001199643,0.00005466325,0.0001675815,0.0000748952,0.000110039,0.001567515],"category_scores_gemma":[0.00005500324,0.00005444771,0.0001180822,0.00007675031,0.00008387838,0.00009055405,0.00008589034,0.000376286,0.0003262279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001265263,"about_ca_system_score_gemma":0.00009653612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001264183,"about_ca_topic_score_gemma":0.0002031779,"domain_scores_codex":[0.9999481,0.00001028043,0.000003795517,0.000007796709,0.0000157207,0.00001424357],"domain_scores_gemma":[0.999977,0.000003639873,0.00000669684,0.000002743161,0.000002170998,0.000007802066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003444611,0.00007216326,0.000171195,0.00003008935,0.000005887382,0.00003253701,0.000007095045,0.0001705188,0.994753,0.00006152082,0.0001460527,0.004205458],"study_design_scores_gemma":[0.00002664933,0.0009012737,0.002183786,0.000003854788,0.0000133089,0.0001595764,0.000008070314,0.0009131434,0.9933443,0.00002559109,0.00241849,0.000001914617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993455,0.001629557,0.00165961,0.000108503,0.00005630256,0.00002777229,0.0002954635,0.0001093092,0.0026586],"genre_scores_gemma":[0.9956137,0.0007079175,0.001414288,0.00004302544,0.00001959217,0.00001754719,0.0002640448,0.00001294664,0.001906928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001567515,"threshold_uncertainty_score":0.005243838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01231609409758963,"score_gpt":0.2376792740582465,"score_spread":0.2253631799606568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}